Nicotine |
| Nicotine | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| The skeletal formula of nicotine | |||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||
| Common names | Nicotine | ||||||||||||||||||||||
| Systematic name | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine | ||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||
|
|
|||||||||||||||||||||||
| Summary sheet: Nicotine |
Nicotine is a potent naturally occurring alkaloid found in the nightshade family of plants (Solanaceae) and a stimulant drug. It is most commonly found within tobacco.
Contents
Chemistry
Nicotine, or (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, is a synthetic bicyclic compound comprised of a pyrrolidine ring attached to the second carbon of a pyridine ring. Pyridine is a six-membered ring structurally related to benzene with a nitrogen member. Nicotine additionally contains an N-substituted (R1) pyrrolidine ring. These rings are bridged from R3 of the pyridine ring to R2 of the pyrrolidine ring. Both optical enantiomers of nicotine are active, with the naturally occurring levorotatory enantiomer being more active and more toxic than the dextrorotatory. In its basic form, it is an oily liquid that is miscible with water. However, as a nitrogenous base nicotine readily forms solid, water soluble salts when acidified.
Pharmacology
Nicotine produces its stimulating effects by agonising nicotinic acetylcholine receptors, causing the liver to release glucose and the adrenal medulla to release epinephrine (adrenaline).
Once it reaches the brain, nicotine stimulates the release of many neurotransmitters and hormones including acetylcholine, norepinephrine, epinephrine, arginine vasopressin, serotonin, dopamine, and beta-endorphin[1][2], which are responsible for the majority of its psychoactive effects.
By increasing the level of acetylcholine in the brain, nicotine enhances concentration. Norepinephrine release causes enhanced alertness and arousal. With low doses, nicotine enhances the action of norepinephrine and dopamine, which produces typical psychostimulation. Nicotine also has sedative effects as produced by the release of beta-endorphin (which reduces anxiety) and enhances the action of serotonin and opioids (which causes sedation).
Bioavailability
- Oral: 20% - 45%
- Intranasal: 53%
- Transdermal: 68%
Metabolism
Nicotine has a half-life of 1 - 2 hours when administered in a single dose and an active metabolite (cotinine) with a half-life of 20 hours.
Subjective effects
The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.
Physical effects
- Stimulation and Sedation - The stimulatory effects of nicotine are much less pronounced than other stimulants such as caffeine or amphetamine. At higher doses, however, nicotine inhibits nerve transmission which produces sedative effects.
- Abnormal heartbeat - At high doses, nicotine can trigger an elevated heart rate or even heart palpitations.
- Vasoconstriction
- Appetite suppression
- Dizziness - At high doses, nicotine can cause one to feel dizzy or lightheaded.
Cognitive effects
- Thought acceleration
- Focus enhancement
- Memory enhancement
- Motivation enhancement
- Euphoria
- Anxiety and Anxiety suppression - Low doses of nicotine produce stimulatory effects which can cause anxiety. Higher doses stimulate the release of beta-endorphin which relieves anxiety.
- Sexual arousal - Nicotine has the capability of inducing heightened sexual arousal due to its effect on dopamine transmission.
- Compulsive redosing
Forms
Tobacco
The most common source of nicotine is Nicotiana Tabacum, constituting 0.6% - 3.0% of its dry weight.[3] It is also present in other species of Nightshade (Solanaceae) such as Indian Tobacco (Nicotiana Rustica).
Nicotine Replacement Therapy
Nicotine is also available in several forms which can be administered without smoking. Popular products include sublingual lozenges and sprays, dermal patches, inhalers, and solutions used for oral use or in conjunction with a vaporiser.
Toxicity and harm potential
Lethal dosage
Nicotine has an estimated oral LD50 of 6.5 - 13 mg/kg in humans, which is much lower than many other common stimulants. It is unlikely that overdose can be achieved by smoking tobacco, however, coadministration with other sources of nicotine such as patches or gum may potentially be dangerous.
Nicotine readily passes through the dermis and into the bloodstream upon contact with skin, so safety precautions should be taken when handling it in its pure form.
Tolerance and addiction potential
Nicotine activates the reward system (mesolimbic pathway) of the brain, which is responsible for its addictive nature. Because of this, tobacco smoking is as addictive as cocaine or heroin, which both have similar mechanisms of addiction.
Chronic use of nicotine, as with many other addictive drugs, downregulates the production of dopamine and other stimulatory neurotransmitters and also desensitises nicotinic acetylcholine receptors. In response, the brain upregulates the number of receptors presented. The net effect is an increase in sensitivity to the reward system; the opposite of the decrease in sensitivity as caused by addictive drugs like cocaine and heroin.
Following discontinuation of nicotine, receptors may take several months to return to baseline.
Pregnancy
Nicotine has been indicated in the increased frequency of birth defects, and has been correlated with the increase of attention deficit hyperactive disorder in children.
Legal issues
Nicotine is legal all over the world and as such is one of the most popularly used drugs. The sale of tobacco products are usually restricted to adults, and they are often heavily taxed.
See also
References
- ↑ Pomerleau OF, Pomerleau CS (1984). Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation. Neuroscience and Biobehavioral Reviews, 8:503-513.
- ↑ Pomerleau OF, Rosecrans J (1989). Neuroregulatory effects of nicotine. Psychoneuroendocrinology 14:407-423.
- ↑ http://www.sciencedirect.com/science/article/pii/S187853521000211X%7CAnalytical determination of nicotine in tobacco leaves by gas chromatography–mass spectrometry
- ↑ Development of a rational scale to assess the harm of drugs of potential misuse | http://www.sciencedirect.com/science/article/pii/S0140673607604644